| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_41a639aa11b9b2f8063a3e6b8b22b557
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_700ff9a01db2075489cb7ed87392dc28 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-96486
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-224
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-755 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-573 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-56 |
| filingDate |
2013-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2014-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4195e60db771c2d0973cf93e757ba256
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_624da27805cbf5f3b12060aed8d5c9e0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2dfd17f55335d3a3d3850f918fe02056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_815dd609897b6bf80806b57ff0e648c2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50adf47e9018ed5545286bffca6843ce |
| publicationDate |
2014-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8623612-B2 |
| titleOfInvention |
Method for testing treatment of ADAMTS13 deficiency |
| abstract |
The invention generally relates to methods of measuring cleaved von Willebrand factor (VWF) fragments. More specifically, the invention relates to methods of measuring the ability of a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13 (ADAMTS13) to cleave VWF in vivo. The invention also relates to methods of using various animal models which demonstrate ADAMTS13 activity similar to that of a human. The invention further relates to methods of measuring the cleavage products of rVWF in mammals, particularly in humans and in human plasma. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10209263-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9110085-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9488651-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016033506-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10858689-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10900979-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019145989-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014154709-A1 |
| priorityDate |
2008-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |